scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will participate in a fireside chat at the Cowen 43rd Annual Health Care Conference on March 8 at 10:30 am ET in Boston. This event will highlight the company's focus on developing and commercializing products aimed at optimizing the delivery of infused therapies and improving patient care while reducing healthcare costs. Tucker will also meet with investors from March 6 to 8. A live webcast of the chat will be available on the company's website under the Investor Relations section.

News Market Reaction – SCPH

+5.31%

+5.31% Session move

In the trading session that priced this news, SCPH gained 5.31%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to participate in a fireside chat at the Cowen 43^rd Annual Health Care Conference, on Wednesday, March 8 at 10:30 am ET in Boston. Mr. Tucker will also be meeting with investors March 6 – 8.

A live webcast of the fireside chat can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

FAQ

When is scPharmaceuticals participating in the Cowen 43rd Annual Health Care Conference?

scPharmaceuticals will participate in the Cowen 43rd Annual Health Care Conference on March 8 at 10:30 am ET.

Who is the CEO of scPharmaceuticals?

The CEO of scPharmaceuticals is John Tucker.

What is the primary focus of scPharmaceuticals?

scPharmaceuticals focuses on developing and commercializing products that optimize the delivery of infused therapies and improve patient care.

Where can I watch the live webcast of scPharmaceuticals' fireside chat?

The live webcast can be accessed on the scPharmaceuticals website under the Investor Relations section.

What are the dates for investor meetings held by scPharmaceuticals?

Investor meetings will be held from March 6 to March 8, 2023.